EBOS Group Limited (EBOSF)

21.01 0.00 (0.00%) As of 10:28AM EST. Market open.

EBOS Group Limited

737 Bourke Street
Level 7
Docklands, VIC 3008
Australia
61 3 9918 5555
https://www.ebosgroup.com

Sector(s): 
Industry: 
Full-time employees: 5,000

Key executives

Name	Title	Pay	Exercised	Year born
Mr. John Cullity	Chief Exec. Officer	2.24M	N/A	N/A
Mr. Leonard Hansen	CFO & Chief Accountant	N/A	N/A	N/A
Ms. Andrea Bell	Chief Information Officer	N/A	N/A	N/A
Martin Krauskopf	Exec. GM of Strategy, Mergers & Acquisitions and GM of Investor Relations	N/A	N/A	N/A
Ms. Janelle Cain	Gen. Counsel	N/A	N/A	N/A
Ms. Jacinta McCarthy	Group Gen. Mang. of HR	N/A	N/A	N/A
Mr. Simon Bunde	Exec. Gen. Mang. of Strategic Operations, ESG & Innovation	N/A	N/A	N/A
Ms. Julie Dillon	Chief Exec. Officer of Animal Care	N/A	N/A	N/A
Mr. Matthew Muscio	Chief Exec. Officer of Medical Technology	N/A	N/A	N/A
Mr. Brett Barons	Chief Exec. Officer of Symbion	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and internationally. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and multi-brand retail pharmacy services. It also offers vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; community based health care services and programs; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers contract logistics services, such as healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition and food products, treats, clean-up products, grooming, and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

Corporate governance

EBOS Group Limited’s ISS governance QualityScore as of 1 February 2023 is 10. The pillar scores are Audit: 4; Board: 10; Shareholder rights: 1; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.